cannabis

Can cannabis succeed where other compounds have failedUse of a novel semi-fluorinated alkane drug delivery technology as a vehicle to deliver cannabinoids to the ocular surface reached target tissues without systemic side effects in preclinical studies.
DIR Fees, Medical Marijuana Among Hot Topics at NCPA ConventionWhat you need to know about the upcoming NCPA convention.
Why a Pharmacy School Cancelled Marijuana Classes
Why a Pharmacy School Cancelled Marijuana ClassesMedical cannabis classes will no longer be held at the University of Maryland-Baltimore.
The Top 7 Craziest Drugs in the Pipeline
The Top 7 Craziest Drugs in the PipelineNot all drugs are incredible—and sometimes even the incredible ones have weird origins.
Cannabis for Credits
Cannabis for CreditsClinical rotation gives students unique view of medical cannabis industry.
State medical marijuana laws continue to expandMedical marijuana’s therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly.
Cannabinoid-based drug pipeline shows promise
Cannabinoid-based drug pipeline shows promiseNew treatment indications are under investigation for the use of cannabinoid-based drugs.
A Solution to the Opioid Crisis?
A Solution to the Opioid Crisis?A new study finds that patients many patients prefer cannabis to prescribed opioids.
Cannabinoid-based drug pipeline grows: 4 ways to prepareNew treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?
Cannabis remains problematic for glaucoma
Cannabis remains problematic for glaucomaDespite the legalization of marijuana by several state governments, physicians should not recommend smoking it as a treatment for glaucoma, said Sunita Radhakrishnan, MD. “It has been approved by public opinion rather than regulatory process,” she said.